Jacobo Mintzer
Psychiatry · Charleston, SCNPI 1518075563
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $100,659 of the $132,037 with a category attached, or 76.2%. 14 manufacturers reported payments, led by Acadia Pharmaceuticals Inc at 41.2% of the total. Reporting peaked in 2020 at $46,992 and has fallen 61.8% since, to $17,936 in 2025. Among psychiatry clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 86 payments — averaging $1535.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acadia Pharmaceuticals Inc$54K
- Genentech, Inc.$17K
- Avanir Pharmaceuticals, Inc.$17K
- Axsome Therapeutics, Inc.$9K
- Genentech USA, Inc.$8K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$6K
- plus $20K from 8 others
Across 161 payments — averaging $29,759 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$1.6M
- Eisai Inc.$1.2M
- Eli Lilly$885K
- Biogen$573K
- Takeda Pharmaceuticals U.S.A., Inc.$148K
- Janssen Research & Development, LLC$113K
- plus $297K from 11 others
What the payments were for
- Consulting fees$100,65976%
- Speaking & faculty fees$23,90818%
- Travel & lodging$6,2775%
- Food & beverage$1,1931%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acadia Pharmaceuticals Inc | 39 | $54,450 |
| Genentech, Inc. | 11 | $17,268 |
| Avanir Pharmaceuticals, Inc. | 10 | $16,730 |
| Axsome Therapeutics, Inc. | 3 | $9,144 |
| Genentech USA, Inc. | 6 | $8,495 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $5,832 |
| H. Lundbeck A S | 5 | $5,710 |
| Corium, LLC | 2 | $4,950 |
| Biogen | 3 | $3,171 |
| Lundbeck LLC | 1 | $3,000 |
| Novo Nordisk | 1 | $2,430 |
| Grifols Biologicals LLC | 2 | $748 |
| Eisai Inc. | 1 | $103 |
| Sumitomo Pharma Co., Ltd. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUPLAZID$42,251
- REXULTI$8,710
- Non-Covered Product$6,822
- ADLARITY$4,950
- DISEASE EDUCATION$3,600
- ACP-204$1,800
- Albutein$748
- Flebogamma DIF$748
How this compares
$132,037 in reported general payments places this provider in the 95th percentile of 624 psychiatry providers in South Carolina.
Other psychiatry in Charleston
- Ricardo FermoCharleston$262K
- Floyd SalleeCharleston$121K
- Kathleen BradyCharleston$83K
- Jordan SpencerCharleston$62K
- James BallengerCharleston$35K
- Mark HamnerCharleston$24K
- Constance AlexanderCharleston$20K
- Mark GeorgeCharleston$17K
- Lalithkumar SolaiCharleston$12K
- Michael WilcoxCharleston$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.